Journal of Southern Medical University
Clinical efficacy of anlotinib plus S-1 as a second-line therapy for recurrent or metastatic esophageal squamous cell carcinoma
孙 魏, 邹 玺, 张 微, 胡守友, 葛科伟
Journal of Southern Medical University . 2021, (2): 250 -255 .  DOI: 10.12122/j.issn.1673-4254.2021.02.13